RecruitingNot ApplicableNCT06525584

Ketamine Infusion as a Method of Cerebral Protection in Children

Ketamine Infusion in the Postoperative Period as a Method of Cerebral Protection in Children During Surgical Correction of Congenital Heart Defects

Sponsor

Kemerovo State Medical University

Enrollment

196 participants

Start Date

Nov 5, 2023

Study Type

INTERVENTIONAL

Conditions

Brain Injuries

Summary

The study is devoted to the use of ketamine infusion in a subanesthetic dose in the postoperative period in children after surgical correction of congenital heart defects in children.

Eligibility

Min Age: 1 MonthMax Age: 5 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Control, a drug called Ketamine Hcl 50Mg/Ml Inj, and others for people with brain injuries. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Month to 5 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.